Healthcare and Life Sciences 50 – 2016

John F. Neylan III/Keryx Biopharmaceuticals

Dr. John F. Neylan III is the senior vice president and chief medical officer at Keryx Biopharmaceuticals, where he leads the development of novel therapeutics for patients with kidney disease. Recently, he and his team successfully completed a landmark clinical trial in patients with chronic kidney disease and iron deficiency anemia.

John previously served as the senior vice president in clinical development at Genzyme Corporation, an industry leader in the development of therapeutics for specialty metabolic diseases, and as vice president of research and development with Wyeth Research, where he directed clinical research in a wide range of therapeutic areas. Prior to establishing himself in the pharmaceutical industry, he held many eminent academic positions in nephrology and organ transplantation, such as professor of medicine at Emory University and president of the American Society of Transplantation. He has authored over 70 scientific manuscripts and book chapters and is an inductee in the Alpha Omega Alpha Medical Honor Society.

John’s Irish roots trace back to Ennistymon, Co. Clare on his father’s side, and Muine Bheag, Co. Carlow, on his mother’s. He currently lives in Boston, Massachusetts with his wife, Cynthia, and children, John Francis IV, Elizabeth Marie, and James Christopher. They share a great pleasure in visits to Ireland to explore the roots of their treasured heritage.